SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5161 JMM: I am a resident bull on occasion. The thread includes two clear "tascaram(o)uche-8/14/1998
5160 AGPH is very weak right now. Watch out if it breaks 23 convincingly. ItSteve Fancy-8/14/1998
5159 .....I understand that you are the resident bull on this stk and try to explainJMM-8/14/1998
5158 >> Life Sciences for DuPont goes beyond biotech and includes plant scienscaram(o)uche-8/14/1998
5157 Life Sciences for DuPont goes beyond biotech and includes plant sciences, somewJoe E.-8/14/1998
5156 Peter: Well, there's BGEN, IDPH, etc. But, nothing makes sense like AGPH,scaram(o)uche-8/14/1998
5155 I haven't reviewed the details of Sustiva. However, if there is any suspicbiodoc-8/14/1998
5154 Rick, hmmm ... did you see this comment from DD's CEO? <<[we] are Peter Singleton-8/14/1998
5153 John: I am a value type, you have me pegged. But I have plenty of stocks withJoe E.-8/13/1998
5152 You've dropped in from visitor land to give us all sorts of opinions about scaram(o)uche-8/13/1998
5151 Joe, _most_ biotech investors invest in companies that spend fortunes on researJohn Metcalf-8/13/1998
5150 Well, I'm no a fan of the stock split because I think it makes the company Joe E.-8/13/1998
5149 OTOTOTOT <<It's ironic that its a disease that people want to controsam-8/13/1998
5148 ......those aren't the major mkts which have the high incidence of the diseJMM-8/13/1998
5147 More on the tracking stock: They say about 25% of the R&D expense goes witBiomaven-8/13/1998
5146 <<It's ironic that its a disease that people want to control and haveZirdu-8/13/1998
5145 looks like a bit of short covering this afternoon. it Intel Trader-8/13/1998
5144 JMM: <<No where in the overseas mkt can they afford the cost associated wJoe E.-8/13/1998
5143 Monthly scrip data for July... New 18086 up 0.7% from 17955 Refills 33,273 up Steve Fancy-8/13/1998
5142 Look forward to your evaluation Peter...thanks. - sf <eom> sf Steve Fancy-8/13/1998
5141 The details of the tracking stock proposal are now available at www.freedgar.coBiomaven-8/13/1998
5140 Well folks, doesn't appear that the street cares a whole lot about AGPH&Steve Fancy-8/13/1998
5139 ......she apparently does her homework on the issue......one aspect that peopleJMM-8/13/1998
5138 Thanks for the correction, Biodoc. As to the main point, that Sustiva is broadJohn Metcalf-8/13/1998
5137 My whole investment in AGPH has been a "tax-free event". :-) John IJohn F Beule-8/13/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News